Prenatal immune status of fetuses of HIV-seropositive mothers

A. Plebani, A. Biolchini, A. Bucceri, M. Buscaglia, G. Pardi, A. E. Semprini

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Human immunodeficiency virus (HIV) has been isolated from fetal tissues as early as 13 weeks and later from fetal blood. These findings have raised the possibility of prenatal diagnosis of infected fetuses by identification of the virus in the fetal compartment. Study of the fetal immune status has proved reliable in prenatal diagnosis of congenital immunodeficiency, and we have tested the possibility to diagnose acquired immunodeficiency in utero by this approach. We studied T lymphocyte subsets and their mitogenic response in fetal blood obtained after elective termination at midgestation in 8 cases and at delivery in 26 cases of maternal HIV infection. Results have been compared to appropriate normal controls. No significant difference was found in terms of total lymphocytes, CD4 and CD8 populations and phytohemagglutinin responses. This indicates either that immunological parameters currently used to assess postnatal immunodeficiency are not reliable during intrauterine life or that the intrauterine environment and the transplacental passage of maternal antibodies interfere with development of prenatal immunodeficiency.

Original languageEnglish
Pages (from-to)108-111
Number of pages4
JournalGynecologic and Obstetric Investigation
Volume29
Issue number2
Publication statusPublished - 1990

Fingerprint

Prenatal Diagnosis
Fetal Blood
Fetus
Mothers
HIV
T-Lymphocyte Subsets
Phytohemagglutinins
Virus Diseases
Lymphocytes
Viruses
Antibodies
Population

Keywords

  • congenital immunodeficiency
  • Human immunodeficiency virus
  • prenatal immune status

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Plebani, A., Biolchini, A., Bucceri, A., Buscaglia, M., Pardi, G., & Semprini, A. E. (1990). Prenatal immune status of fetuses of HIV-seropositive mothers. Gynecologic and Obstetric Investigation, 29(2), 108-111.

Prenatal immune status of fetuses of HIV-seropositive mothers. / Plebani, A.; Biolchini, A.; Bucceri, A.; Buscaglia, M.; Pardi, G.; Semprini, A. E.

In: Gynecologic and Obstetric Investigation, Vol. 29, No. 2, 1990, p. 108-111.

Research output: Contribution to journalArticle

Plebani, A, Biolchini, A, Bucceri, A, Buscaglia, M, Pardi, G & Semprini, AE 1990, 'Prenatal immune status of fetuses of HIV-seropositive mothers', Gynecologic and Obstetric Investigation, vol. 29, no. 2, pp. 108-111.
Plebani A, Biolchini A, Bucceri A, Buscaglia M, Pardi G, Semprini AE. Prenatal immune status of fetuses of HIV-seropositive mothers. Gynecologic and Obstetric Investigation. 1990;29(2):108-111.
Plebani, A. ; Biolchini, A. ; Bucceri, A. ; Buscaglia, M. ; Pardi, G. ; Semprini, A. E. / Prenatal immune status of fetuses of HIV-seropositive mothers. In: Gynecologic and Obstetric Investigation. 1990 ; Vol. 29, No. 2. pp. 108-111.
@article{bbb886a0dfab440fbf3197ad39df7dc9,
title = "Prenatal immune status of fetuses of HIV-seropositive mothers",
abstract = "Human immunodeficiency virus (HIV) has been isolated from fetal tissues as early as 13 weeks and later from fetal blood. These findings have raised the possibility of prenatal diagnosis of infected fetuses by identification of the virus in the fetal compartment. Study of the fetal immune status has proved reliable in prenatal diagnosis of congenital immunodeficiency, and we have tested the possibility to diagnose acquired immunodeficiency in utero by this approach. We studied T lymphocyte subsets and their mitogenic response in fetal blood obtained after elective termination at midgestation in 8 cases and at delivery in 26 cases of maternal HIV infection. Results have been compared to appropriate normal controls. No significant difference was found in terms of total lymphocytes, CD4 and CD8 populations and phytohemagglutinin responses. This indicates either that immunological parameters currently used to assess postnatal immunodeficiency are not reliable during intrauterine life or that the intrauterine environment and the transplacental passage of maternal antibodies interfere with development of prenatal immunodeficiency.",
keywords = "congenital immunodeficiency, Human immunodeficiency virus, prenatal immune status",
author = "A. Plebani and A. Biolchini and A. Bucceri and M. Buscaglia and G. Pardi and Semprini, {A. E.}",
year = "1990",
language = "English",
volume = "29",
pages = "108--111",
journal = "Gynecologic and Obstetric Investigation",
issn = "0378-7346",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Prenatal immune status of fetuses of HIV-seropositive mothers

AU - Plebani, A.

AU - Biolchini, A.

AU - Bucceri, A.

AU - Buscaglia, M.

AU - Pardi, G.

AU - Semprini, A. E.

PY - 1990

Y1 - 1990

N2 - Human immunodeficiency virus (HIV) has been isolated from fetal tissues as early as 13 weeks and later from fetal blood. These findings have raised the possibility of prenatal diagnosis of infected fetuses by identification of the virus in the fetal compartment. Study of the fetal immune status has proved reliable in prenatal diagnosis of congenital immunodeficiency, and we have tested the possibility to diagnose acquired immunodeficiency in utero by this approach. We studied T lymphocyte subsets and their mitogenic response in fetal blood obtained after elective termination at midgestation in 8 cases and at delivery in 26 cases of maternal HIV infection. Results have been compared to appropriate normal controls. No significant difference was found in terms of total lymphocytes, CD4 and CD8 populations and phytohemagglutinin responses. This indicates either that immunological parameters currently used to assess postnatal immunodeficiency are not reliable during intrauterine life or that the intrauterine environment and the transplacental passage of maternal antibodies interfere with development of prenatal immunodeficiency.

AB - Human immunodeficiency virus (HIV) has been isolated from fetal tissues as early as 13 weeks and later from fetal blood. These findings have raised the possibility of prenatal diagnosis of infected fetuses by identification of the virus in the fetal compartment. Study of the fetal immune status has proved reliable in prenatal diagnosis of congenital immunodeficiency, and we have tested the possibility to diagnose acquired immunodeficiency in utero by this approach. We studied T lymphocyte subsets and their mitogenic response in fetal blood obtained after elective termination at midgestation in 8 cases and at delivery in 26 cases of maternal HIV infection. Results have been compared to appropriate normal controls. No significant difference was found in terms of total lymphocytes, CD4 and CD8 populations and phytohemagglutinin responses. This indicates either that immunological parameters currently used to assess postnatal immunodeficiency are not reliable during intrauterine life or that the intrauterine environment and the transplacental passage of maternal antibodies interfere with development of prenatal immunodeficiency.

KW - congenital immunodeficiency

KW - Human immunodeficiency virus

KW - prenatal immune status

UR - http://www.scopus.com/inward/record.url?scp=0025350038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025350038&partnerID=8YFLogxK

M3 - Article

C2 - 2335309

AN - SCOPUS:0025350038

VL - 29

SP - 108

EP - 111

JO - Gynecologic and Obstetric Investigation

JF - Gynecologic and Obstetric Investigation

SN - 0378-7346

IS - 2

ER -